JavaScript is NOT enabled !

Please enable JavaScript.

Article

PubMed

This record comes from PubMed

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

Sessa, C
Author Sessa, C Medical Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland
Balmaña, J
Author Balmaña, J Medical Oncology Hospital Vall d'Hebron and Hereditary Cancer Genetics Group, Vall d'Hebron Institut of Oncology, Barcelona, Spain
Bober, S L
Author Bober, S L Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute/Harvard Medical School, Boston, USA
Cardoso, M J
Author Cardoso, M J Champalimaud Foundation, Breast Unit and Faculdade de Medicina, Lisbon, Portugal
Colombo, N
Author Colombo, N Department of Gynecologic Oncology, Istituto Europeo di Oncologia e IRCCS, Milan, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Curigliano, G
Author Curigliano, G Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy
Domchek, S M
Author Domchek, S M Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
Evans, D G
Author Evans, D G Manchester Centre for Genomic Medicine, Division of Evolution Infection and Genomic Sciences, University of Manchester, MAHSC, Manchester, UK; Manchester Centre for Genomic Medicine, MAHSC, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK
Fischerova, D
Author Fischerova, D Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
Harbeck, N
Author Harbeck, N Breast Center, Department of Obstetrics & Gynecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany
Kuhl, C
Author Kuhl, C Department of Diagnostic and Interventional Radiology, University Hospital Aachen, University Hospital Aachen (UKA), RWTH Aachen, Germany
Lemley, B
Author Lemley, B KIU - Patient Organisation for Women with Gynaecological Cancer, Copenhagen, Denmark; Clinical Trials Project, ESGO ENGAGe, Prague, Czech Republic
Levy-Lahad, E
Author Levy-Lahad, E Medical Genetics Institute, Shaare Zedek Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
Lambertini, M
Author Lambertini, M Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
Ledermann, J A
Author Ledermann, J A Department of Oncology, UCL Cancer Institute, University College London and UCL Hospitals, London, UK
Loibl, S
Author Loibl, S GBG Forschungs GmbH, Neu-Isenburg, Germany
Phillips, K-A
Author Phillips, K-A Department of Medical Oncology, Peter MacCallum Cancer Centre and The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
Paluch-Shimon, S
Author Paluch-Shimon, S Sharett Institute of Oncology Department, Hadassah University Hospital & Faculty of Medicine Hebrew University, Jerusalem, Israel
ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Author ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

Annals of oncology. 2023 Jan ; 34 (1) : 33-47. [epub] 20221025

Ann Oncol
ISSN 1569-8041 | 0923-7534
Source

Language English Country England, Great Britain Media print-electronic

Document type Practice Guideline, Research Support, Non-U.S. Gov't, Journal Article

Persistent link https://www.medvik.cz/link/pmid36307055

PubMed 36307055
DOI 10.1016/j.annonc.2022.10.004
PII: S0923-7534(22)04193-X
Knihovny.cz E-resources

Keywords
BRCA, ESMO Clinical Practice Guideline, hereditary breast and ovarian cancer syndromes, risk reduction,
MeSH
Early Detection of Cancer MeSH
Risk Reduction Behavior MeSH
Neoplastic Syndromes, Hereditary * MeSH
Genetic Predisposition to Disease MeSH
Humans MeSH
Breast Neoplasms * diagnosis genetics prevention & control MeSH
Ovarian Neoplasms * diagnosis epidemiology genetics MeSH
Check Tag
Humans MeSH
Female MeSH
Publication type
Journal Article MeSH
Research Support, Non-U.S. Gov't MeSH
Practice Guideline MeSH

Basser Center for BRCA Abramson Cancer Center University of Pennsylvania Philadelphia USA

Breast Center Department of Obstetrics and Gynecology and Comprehensive Cancer Center Munich LMU University Hospital Munich Germany

Champalimaud Foundation Breast Unit and Faculdade de Medicina Lisbon Portugal

Department of Diagnostic and Interventional Radiology University Hospital Aachen University Hospital Aachen RWTH Aachen Germany

Department of Gynecologic Oncology Istituto Europeo di Oncologia e IRCCS Milan Italy; Department of Medicine and Surgery University of Milano Bicocca Milan Italy

Department of Internal Medicine and Medical Specialties School of Medicine University of Genova Genoa Italy; Department of Medical Oncology U O Clinica di Oncologia Medica IRCCS Ospedale Policlinico San Martino Genoa Italy

Department of Medical Oncology Peter MacCallum Cancer Centre and The Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne Australia

Department of Oncology UCL Cancer Institute University College London and UCL Hospitals London UK

Department of Psychosocial Oncology and Palliative Care Dana Farber Cancer Institute Harvard Medical School Boston USA

Early Drug Development for Innovative Therapies Division Istituto Europeo di Oncologia IRCCS Milan Italy; Department of Oncology and Hemato Oncology University of Milano Milan Italy

GBG Forschungs GmbH Neu Isenburg Germany

Gynecologic Oncology Center Department of Obstetrics and Gynecology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

KIU Patient Organisation for Women with Gynaecological Cancer Copenhagen Denmark; Clinical Trials Project ESGO ENGAGe Prague Czech Republic

Manchester Centre for Genomic Medicine Division of Evolution Infection and Genomic Sciences University of Manchester MAHSC Manchester UK; Manchester Centre for Genomic Medicine MAHSC St Mary's Hospital Manchester University Hospitals NHS Foundation Trust Manchester UK

Medical Genetics Institute Shaare Zedek Medical Center Faculty of Medicine The Hebrew University of Jerusalem Jerusalem Israel

Medical Oncology Hospital Vall d'Hebron and Hereditary Cancer Genetics Group Vall d'Hebron Institut of Oncology Barcelona Spain

Medical Oncology Oncology Institute of Southern Switzerland EOC Bellinzona Switzerland

Sharett Institute of Oncology Department Hadassah University Hospital and Faculty of Medicine Hebrew University Jerusalem Israel

References provided by Crossref.org

Newest 20 citations...

See more in
Medvik | PubMed

A retrospective single-center pilot study of the genetic background of the transplanted kidney

PloS one. 2025 ; 20 (1) : e0316192. [epub] 20250108

PLoS One
ISSN 1932-6203
Source

Primary retroperitoneal nodal endometrioid carcinoma associated with Lynch syndrome: A case report

Frontiers in oncology. 2023 ; 13 () : 1092044. [epub] 20230221

Front Oncol
ISSN 2234-943X
Source

Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic

Cancers. 2023 Feb 08 ; 15 (4) : . [epub] 20230208

Cancers (Basel)
ISSN 2072-6694
Source

Borrow
RIS

Find record

In BMC

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

Find record

Citation metrics

Archiving options